Haploinsufficient phenotypes promote selection of PTEN and ARID1A-deficient clones in human colon
Cancer driver mutations are defined by their high prevalence in cancers and presumed rarity in normal tissues. However, recent studies show that positive selection in normal epithelia can increase the prevalence of some cancer drivers. To determine their true cancer-driving potential, it is essentia...
| Main Authors: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Springer
2025
|
| _version_ | 1826317782898180096 |
|---|---|
| author | Skoufou-Papoutsaki, N Adler, S Mehmed, S Tume, C Olpe, C Morrissey, E Kemp, R Girard, A Moutin, EB Chilamakuri, CSR Miller, JL Lindskog, C Werle, F Marks, K Perrone, F Zilbauer, M Tourigny, DS Winton, DJ |
| author_facet | Skoufou-Papoutsaki, N Adler, S Mehmed, S Tume, C Olpe, C Morrissey, E Kemp, R Girard, A Moutin, EB Chilamakuri, CSR Miller, JL Lindskog, C Werle, F Marks, K Perrone, F Zilbauer, M Tourigny, DS Winton, DJ |
| author_sort | Skoufou-Papoutsaki, N |
| collection | OXFORD |
| description | Cancer driver mutations are defined by their high prevalence in cancers and presumed rarity in normal tissues. However, recent studies show that positive selection in normal epithelia can increase the prevalence of some cancer drivers. To determine their true cancer-driving potential, it is essential to evaluate how frequent these mutations are in normal tissues and what are their phenotypes. Here, we explore the bioavailability of somatic variants by quantifying age-related mutational burdens in normal human colonic epithelium using immunodetection in FFPE samples (N = 181 patients). Positive selection of variants of tumour suppressor genes PTEN and ARID1A associates with monoallelic gene loss as confirmed by CRISPR/Cas9 mutagenesis and changes in their downstream effectors. Comparison of the mutational burden in normal tissue and colorectal cancers allows quantification of cancer driver potency based on relative representation. Additionally, immune exclusion, a cancer hallmark feature, is observed within ARID1A-deficient clones in histologically normal tissue. The behaviour resulting from haploinsufficiency of PTEN and ARID1A demonstrates how somatic mosaicism of tumour suppressors arises and can predispose to cancer initiation. |
| first_indexed | 2025-03-11T16:59:23Z |
| format | Journal article |
| id | oxford-uuid:14f80feb-1a4a-43e8-a4ce-d44ad06a8b86 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2025-03-11T16:59:23Z |
| publishDate | 2025 |
| publisher | Springer |
| record_format | dspace |
| spelling | oxford-uuid:14f80feb-1a4a-43e8-a4ce-d44ad06a8b862025-03-10T20:20:55ZHaploinsufficient phenotypes promote selection of PTEN and ARID1A-deficient clones in human colonJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:14f80feb-1a4a-43e8-a4ce-d44ad06a8b86EnglishJisc Publications RouterSpringer2025Skoufou-Papoutsaki, NAdler, SMehmed, STume, COlpe, CMorrissey, EKemp, RGirard, AMoutin, EBChilamakuri, CSRMiller, JLLindskog, CWerle, FMarks, KPerrone, FZilbauer, MTourigny, DSWinton, DJCancer driver mutations are defined by their high prevalence in cancers and presumed rarity in normal tissues. However, recent studies show that positive selection in normal epithelia can increase the prevalence of some cancer drivers. To determine their true cancer-driving potential, it is essential to evaluate how frequent these mutations are in normal tissues and what are their phenotypes. Here, we explore the bioavailability of somatic variants by quantifying age-related mutational burdens in normal human colonic epithelium using immunodetection in FFPE samples (N = 181 patients). Positive selection of variants of tumour suppressor genes PTEN and ARID1A associates with monoallelic gene loss as confirmed by CRISPR/Cas9 mutagenesis and changes in their downstream effectors. Comparison of the mutational burden in normal tissue and colorectal cancers allows quantification of cancer driver potency based on relative representation. Additionally, immune exclusion, a cancer hallmark feature, is observed within ARID1A-deficient clones in histologically normal tissue. The behaviour resulting from haploinsufficiency of PTEN and ARID1A demonstrates how somatic mosaicism of tumour suppressors arises and can predispose to cancer initiation. |
| spellingShingle | Skoufou-Papoutsaki, N Adler, S Mehmed, S Tume, C Olpe, C Morrissey, E Kemp, R Girard, A Moutin, EB Chilamakuri, CSR Miller, JL Lindskog, C Werle, F Marks, K Perrone, F Zilbauer, M Tourigny, DS Winton, DJ Haploinsufficient phenotypes promote selection of PTEN and ARID1A-deficient clones in human colon |
| title | Haploinsufficient phenotypes promote selection of PTEN and ARID1A-deficient clones in human colon |
| title_full | Haploinsufficient phenotypes promote selection of PTEN and ARID1A-deficient clones in human colon |
| title_fullStr | Haploinsufficient phenotypes promote selection of PTEN and ARID1A-deficient clones in human colon |
| title_full_unstemmed | Haploinsufficient phenotypes promote selection of PTEN and ARID1A-deficient clones in human colon |
| title_short | Haploinsufficient phenotypes promote selection of PTEN and ARID1A-deficient clones in human colon |
| title_sort | haploinsufficient phenotypes promote selection of pten and arid1a deficient clones in human colon |
| work_keys_str_mv | AT skoufoupapoutsakin haploinsufficientphenotypespromoteselectionofptenandarid1adeficientclonesinhumancolon AT adlers haploinsufficientphenotypespromoteselectionofptenandarid1adeficientclonesinhumancolon AT mehmeds haploinsufficientphenotypespromoteselectionofptenandarid1adeficientclonesinhumancolon AT tumec haploinsufficientphenotypespromoteselectionofptenandarid1adeficientclonesinhumancolon AT olpec haploinsufficientphenotypespromoteselectionofptenandarid1adeficientclonesinhumancolon AT morrisseye haploinsufficientphenotypespromoteselectionofptenandarid1adeficientclonesinhumancolon AT kempr haploinsufficientphenotypespromoteselectionofptenandarid1adeficientclonesinhumancolon AT girarda haploinsufficientphenotypespromoteselectionofptenandarid1adeficientclonesinhumancolon AT moutineb haploinsufficientphenotypespromoteselectionofptenandarid1adeficientclonesinhumancolon AT chilamakuricsr haploinsufficientphenotypespromoteselectionofptenandarid1adeficientclonesinhumancolon AT millerjl haploinsufficientphenotypespromoteselectionofptenandarid1adeficientclonesinhumancolon AT lindskogc haploinsufficientphenotypespromoteselectionofptenandarid1adeficientclonesinhumancolon AT werlef haploinsufficientphenotypespromoteselectionofptenandarid1adeficientclonesinhumancolon AT marksk haploinsufficientphenotypespromoteselectionofptenandarid1adeficientclonesinhumancolon AT perronef haploinsufficientphenotypespromoteselectionofptenandarid1adeficientclonesinhumancolon AT zilbauerm haploinsufficientphenotypespromoteselectionofptenandarid1adeficientclonesinhumancolon AT tourignyds haploinsufficientphenotypespromoteselectionofptenandarid1adeficientclonesinhumancolon AT wintondj haploinsufficientphenotypespromoteselectionofptenandarid1adeficientclonesinhumancolon |